[Federal Register Volume 66, Number 174 (Friday, September 7, 2001)]
[Notices]
[Pages 46817-46818]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-22455]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 4, 2000, and published in the Federal 
Register on January 10, 2001, (66 FR 2004), Noramco of Delaware, Inc., 
Division of McNeilab, Inc., which has changed its name to Noramco of 
Delaware, Inc., Division of Ortho-McNeil, Inc., 500 Old Swedes Landing 
Road, Wilmington, Delaware 19801, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
distribution to its customers as bulk product.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Noramco of Delaware, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Noramco of Delaware, 
Inc. on a regular basis to ensure that the

[[Page 46818]]

company's continued registration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, audits of the company's 
records, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
above is granted.

    Dated: August 27, 2001.
Laura M. Nagel,
Deputy Assistant Administration, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-22455 Filed 9-6-01; 8:45 am]
BILLING CODE 4410-09-M